S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
Log in
OTCMKTS:CSLLY

Commonwealth Bank of Australia Stock Forecast, Price & News

$110.25
-2.64 (-2.34 %)
(As of 11/30/2020 04:00 PM ET)
Add
Compare
Today's Range
$110.18
Now: $110.25
$111.28
50-Day Range
$101.34
MA: $109.05
$117.74
52-Week Range
$75.19
Now: $110.25
$117.98
Volume44,162 shs
Average Volume48,600 shs
Market Capitalization$100.32 billion
P/E Ratio47.73
Dividend Yield0.86%
Beta0.6
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.98 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CSLLY
CUSIPN/A
CIKN/A
Phone61-3-9389-1911
Employees27,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.15 billion
Cash Flow$2.67 per share
Book Value$7.19 per share

Profitability

Miscellaneous

Market Cap$100.32 billion
Next Earnings DateN/A
OptionableNot Optionable
$110.25
-2.64 (-2.34 %)
(As of 11/30/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CSLLY News and Ratings via Email

Sign-up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Commonwealth Bank of Australia (OTCMKTS:CSLLY) Frequently Asked Questions

How has Commonwealth Bank of Australia's stock price been impacted by Coronavirus?

Commonwealth Bank of Australia's stock was trading at $101.09 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CSLLY stock has increased by 9.1% and is now trading at $110.25.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Commonwealth Bank of Australia?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Commonwealth Bank of Australia in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Commonwealth Bank of Australia
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Commonwealth Bank of Australia?

Wall Street analysts have given Commonwealth Bank of Australia a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Commonwealth Bank of Australia wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Commonwealth Bank of Australia?

Commonwealth Bank of Australia saw a increase in short interest in October. As of October 30th, there was short interest totaling 27,300 shares, an increase of 25.2% from the October 15th total of 21,800 shares. Based on an average daily trading volume, of 66,700 shares, the short-interest ratio is presently 0.4 days.
View Commonwealth Bank of Australia's Short Interest
.

Who are some of Commonwealth Bank of Australia's key competitors?

Who are Commonwealth Bank of Australia's key executives?

Commonwealth Bank of Australia's management team includes the following people:
  • Mr. Paul R. Perreault B.A., MD, CEO & Exec. Director (Age 63, Pay $4.23M)
  • Dr. Paul F. McKenzie, Chief Operating Officer (Age 54, Pay $2.74M)
  • Dr. Robert Andrew Cuthbertson A.O., BMedSci, MBBS, Ph.D., FTSE, FAHMS, AO, Sr. Adviser & Exec. Director (Age 65, Pay $1.48M)
  • Ms. Joy Carolyn Linton BComm, Grad Dip AFI, GAICD, Chief Financial Officer (Age 55)
  • Mr. Mark Dehring, Head of Investor Relations
  • Mr. Gregory Boss B.S., BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel (Age 59)
  • Christina Hickie, Sr. Mang. of Communications
  • Ms. Elizabeth Walker B.A., M.S., Exec. VP & Chief HR Officer (Age 50)
  • Dr. Karen Etchberger, Exec. VP of Quality & Bus. Services (Age 62)
  • Ms. Sharon McHale, Head of Public Affairs

What is Commonwealth Bank of Australia's stock symbol?

Commonwealth Bank of Australia trades on the OTCMKTS under the ticker symbol "CSLLY."

How do I buy shares of Commonwealth Bank of Australia?

Shares of CSLLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Commonwealth Bank of Australia's stock price today?

One share of CSLLY stock can currently be purchased for approximately $110.25.

How big of a company is Commonwealth Bank of Australia?

Commonwealth Bank of Australia has a market capitalization of $100.32 billion and generates $9.15 billion in revenue each year. The company earns $2.10 billion in net income (profit) each year or $2.31 on an earnings per share basis. Commonwealth Bank of Australia employs 27,000 workers across the globe.

What is Commonwealth Bank of Australia's official website?

The official website for Commonwealth Bank of Australia is www.csl.com.au.

How can I contact Commonwealth Bank of Australia?

Commonwealth Bank of Australia's mailing address is 45 Poplar Road, Parkville C3, 3052. The company can be reached via phone at 61-3-9389-1911 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.